documents: FDA-2003-N-0196-0066
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2003-N-0196-0066 | FDA | FDA-2003-N-0196 | Reference 6 - Scientific Committee on Consumer Products (SCCP)/1184/08-SCCNFP Opinion on 4-Methylbenzylidene Camphor (4-MBC) Colipa n° S60 Adopted During the 16th Plenary Meeting of June 24, 2008 re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T18:17:26Z | 0 | 0 | 0900006481a11331 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref